NCT04313790View on ClinicalTrials.gov

Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 29, 2020

Primary Completion Date

October 11, 2022

Study Completion Date

October 11, 2022

Conditions
SepsisCritical Illness
Interventions
DRUG

Heparin Infusion

500 unit heparin infusion \\ hour for DVT prophylaxis experimental group (n=20)

OTHER

subcutaneous heparin

5000 unit subcutaneous heparin /8 hours control group n=(20)

Trial Locations (1)

22511

amira Bisher kassem, Damanhūr Shubrā

All Listed Sponsors
lead

Damanhour University

OTHER

NCT04313790 - Assessment of the Anti-inflammatory Effect of Heparin Infusion Versus Subcutaneous Injection in Septic Patients | Biotech Hunter | Biotech Hunter